Xeroderma pigmentosum, or XP, is an autosomal recessive genetic disorder in which the ability to repair DNA damage caused by ultraviolet (UV) light is deficient. In extreme cases, all exposure to sunlight must be forbidden, no matter how small. As such, individuals with the disease are often colloquially referred to as 'Children of the Night'. Mutations in XP genes that regulate nucleotide excision repair, not only predispose persons with xeroderma pigmentosum to multiple malignancies, but also promote premature cutaneous and ocular ageing, and in some cases promote progressive neurodegenerative changes. There is a great involvement of many parts of the body, especially head and neck. The oral manifestations are mainly related to the occurrence of malignant tumors in the lips, tongue and buccal mucosa. This paper reports a rare case of XP in a 40-year-old female presenting with dermatological, oral and ophthalmological involvement. 
CASE REPORT
An unmarried female patient aged 40 years came to the outpatient Department of Oral Medicine and Radiology with a chief complaint of growth on the lower lip for the past 8 months. History revealed that the growth was initially smaller in size and had gradually increased to the present size. The growth is painful. Initially it was dull and continuous and had increased in intensity since 6 weeks ago. She had consulted a doctor and wedge biopsy was done 2 weeks ago. The growth was histopathologically diagnosed as well differentiated squamous cell carcinoma (SCC) of lower lip and she had come in need of conformation of the diagnosis and subsequent treatment of the growth.
The past medical history revealed that the patient had multiple pigmented lesions all over the face and body, which was noticed right from birth. The patient was under medication right from the first month of infancy till 15th years of age after which the medication were discontinued. The patient was not aware of the medication which was prescribed earlier but vaguely remembers that she was taking steroid tablets. She was advised not to go out in sunlight as it worsened her pigmentations. She was informed at the age 10.5005/jp-journals-10011-1324 of 15 years that at the age of 30 to 35 years, her eye might get affected. She developed gradual clouding of the right eye and redness surrounding the clouding, 4 years ago. She also developed ulcers in the skin all over the face and body during summer months which healed by itself. The depigmentation of the upper and lower lip also increased as the age progressed. The patient did not suffer from any neurodegenerative abnormalities or impairment of intelligence.
Family history revealed that she was born with three siblings who were all girls, and were apparently healthy. Parents had consanguineous marriage and both the parents were apparently healthy. No other medical complications were observed. On extraoral examination, the mouth opening is normal. On lymph node examination, both the right and the left submandibular lymph nodes are palpable, measuring about 1 × 1 cm in the right side and 0.5 × 1 cm in the left side. Both the lymph nodes were firm in consistency, freely movable from the underlying structures and nontender on palpation, with no secondary changes. Multiple macular and depigmentated regions were observed covering the skin of face, body and extremities. Healing ulcers were observed below the right and left eye near the right inner canthus region and left outer canthus region (Fig. 1) . Depigmentation of the entire upper and lower lip was observed. Examination of eye revealed complete clouding in the right eye and initiation of clouding in the left eye. Reddening of the corneal region of the right eye was noticed (Fig. 2) . 
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On examination of the lip, a single proliferative growth measuring about 3 × 2 cm was seen in the left side of the lower lip, 0.5 cm from midline and 1 cm from the left commissure of the lip and extending superiorly to the labial mucosa and inferior to the vermillion border. Multiple fingers like papillary projections were observed on the surface with brownish encrustation (Fig. 3) . On palpation all findings of inspection such as site, size, shape and extent was confirmed. The position was tender, firm in consistency and multiple papillary projections were felt. Another ulcer measuring about 1 × 1.5 cm was observed in the left commissure of the lip, slightly elevated, firm and tender on palpation. A wedge biopsy (Fig. 4) was done on the same day and histopathological report ( Fig. 5 ) revealed it as squamous cell papilloma of the lower lip. So correlating the chief complaint, history of presenting illness, patient's past medical and dermatological history the present clinical features and biopsy report the case was diagnosed as xeroderma pigmentosa with SCC of the lower lip.
The patient was referred to an appropriate Cancer Center for further management of the malignancies.
DISCUSSION
Xeroderma is a term used to refer dry, dispigmented skin and was coined by Hebra and Kaposi in 1874. Later in 1882, the term pigmentosum was added by Kaposi to coin the term 'xeroderma pigmentosum' 1 and hence xeroderma pigmentosum (XP) is variably also known as Kaposi disease. 2 XP is characterized by extreme sensitivity of the skin to sunlight, resulting in sunburn, pigment changes in the skin and greatly elevated incidence of skin cancers. 2 The basic defect in XP is in nucleotide excision repair (NER) defect leading to a defective repair of DNA damaged by ultraviolet (UV) radiation. 3 Defects in NER are results in rare clinical manifestation. XP, Cockayne syndrome (CS) and trichothiodystrophy (TTD) are due to some of the inherited mutations in genes encoding proteins that play critical roles in NER of DNA damage and transcription of mRNA. 4 Kramer et al found an equal sex predilection and significant parental consanguinity, confirming an autosomal recessive inheritance pattern. 5 The incidence of XP seems to vary across the globe. The incidence reported in US and Europe is 1:250,000 and in Japan and other countries at a higher frequency 1:40,000, its incidence is not significant in India. 
PROGRESS OF THE DISEASE
The disease typically passes through 3 stages:
First stage: The skin is healthy at birth and at 6 months after birth there is diffuse reddening of face followed by scaling, freckling and irregular dark spots begins to appear more on the, neck, lower part of the lower limb and trunk.
Second stage: This stage is marked by the development of poikiloderma where there is appearance of irregular patches, both light and dark associated with spider web like collection of blood spots. There is thinning of skin through which blood vessels can be seen.
Third stage: This is a stage of development of solar keratoses and development of numerous malignancies. This development takes place at an early age of 4 to 5 years. This occurs in exposed part of the body like face. The common malignancies of skin that occurs are SCC, or basal cell carcinoma or melanoma. 1 The mean age at diagnosis of XP associated skin cancer is 8 years, 50 years younger than in general population. XP patients below 2 years of age have more than 1,000-fold increased risk of developing skin cancer. 7 Although dark-skinned people have a lower incidence of skin cancer compared to light-skinned people, most probably owing to the photoprotective properties of melanin; dark-skinned and light-skinned people with XP, have similar incidences of skin cancer emphasizing the essential role of DNA repair mechanisms even in the presence of protection by melanin. Melanin which is always thought to be the agent that provides such protection against UV-induced DNA damages is considered to be responsible for the difference in the incidence of premalignant and malignant skin lesions in light-skinned and dark-skinned people. However, the observation that dark-skinned persons with XP develop carcinomas on the pigmented parts of the skin as frequently as light-skinned persons with XP, brings the importance of the protective role of melanin into question. 8 The other complications that develop are ophthalmological and neurological complication. Between 40 and 80% of persons with XP have ocular abnormalities caused by UV-induced DNA alteration to epithelial cells of the conjunctiva, the cornea, and the eyelid. Ocular manifestations include photophobia as the earliest symptom which is a feature of keratitis. Other ocular complications include exposure keratitis, vascularization, ulceration, nodular dystrophy and uveitis. Neurologic defects are detected in 20 to 30% of patients with XP. Microcephaly, delayed motor development, sensory neural deafness are some of the commonly observed neurological complications of XP.
In the general population oral SCC most frequently affects the posterolateral and ventral surfaces of the tongue and floor of the mouth of elderly users of tobacco and alcohol, and runs an aggressive course. By contrast XP associated SCC affects the lip and tip of the tongue of persons younger than 20 years of age and runs a slowly progressive course. Hasan and Khan reported a rare case of XP associated with desquamative gingivitis. 9 This risk of carcinomas in XP has increased in recent years, with the increased use of high intensity discharge light sources such as energy-saving fluorescent lamps which emit higher levels of UVR and blue light than do lowintensity incandescent light sources which emit light toward the yellow/red end of the spectrum.
MANAGEMENT
XP poses a challenge as far as management is concerned as it is a multiorgan and multisystem disease, and usually significant tissue damage would already have occurred by the time a diagnosis is made. Malignant tumors may already have developed by the third or fourth year of life. Early diagnosis and immediate implementation of rigorous sun protection measures may prolong the lives of persons with XP. However, recent information suggests that a normal life span is possible for patients without neurological problems, who are fully protected from UV light. This is achieved by personal protective measures such as long opaque clothing, sun hats, UV protective sun glasses with side shields, long hair styles and custom-made face shields apart from protective films on window, restricting outdoor activities to night time and frequent application of high factor sunscreen even indoors. 2 Surveillance is another important aspect. Dermatologists review once in 3 months ophthalmology examination annually and regular neurological review and hearing tests are worthwhile. Vitamin D supplements may be needed, since sunlight is excluded. Premalignant lesions are treated 
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with topical 5-FU or cryotherapy. Surgical excision of the tumors and grafting of skin from nonlight-exposed areas is the first line of treatment. A new approach to photoprotection is to repair DNA damage after UV exposure by delivering a DNA repair enzyme into the skin by means of specially engineered liposomes.
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CONCLUSION
Prenatal diagnosis is the only way to prevent this disease. This is done by amniocentesis and in vitro cell culture and detection of defective DNA repair. Genetic counseling implicating the effect of consanguineous marriages should be emphasized. There are very few cases of XP reported in literature from India. Reporting every case might help us to know the incidence and prevalence of XP in India which is yet unknown.
